| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.98B | 83.38B | 80.36B | 73.72B | 73.13B | 73.03B |
| Gross Profit | 32.48B | 31.68B | 28.53B | 27.82B | 27.99B | 28.00B |
| EBITDA | 2.81B | 1.41B | 1.33B | 1.81B | 2.54B | 3.34B |
| Net Income | 805.00M | -163.00M | -459.00M | -176.00M | 194.00M | 440.00M |
Balance Sheet | ||||||
| Total Assets | 34.24B | 29.38B | 29.85B | 29.71B | 28.04B | 28.38B |
| Cash, Cash Equivalents and Short-Term Investments | 5.13B | 2.03B | 2.83B | 3.95B | 3.16B | 4.28B |
| Total Debt | 3.90B | 3.90B | 3.80B | 800.00M | 17.00M | 0.00 |
| Total Liabilities | 23.33B | 18.96B | 18.46B | 17.55B | 15.53B | 15.81B |
| Stockholders Equity | 10.91B | 10.42B | 11.39B | 12.16B | 12.51B | 12.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -110.00M | -2.59B | 507.00M | -664.00M | 638.00M |
| Operating Cash Flow | 0.00 | 1.89B | -899.00M | 1.47B | 1.17B | 2.06B |
| Investing Cash Flow | 0.00 | -2.51B | -2.11B | -1.20B | -2.02B | -1.70B |
| Financing Cash Flow | 0.00 | -173.00M | 2.72B | 522.00M | -272.00M | -271.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥95.09B | 104.46 | ― | 0.83% | 1.38% | -87.76% | |
65 Neutral | ¥74.62B | 12.92 | ― | 1.09% | 7.55% | 89.45% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | ¥62.20B | -8.84 | ― | 0.94% | 10.66% | -218.40% | |
51 Neutral | ¥2.13B | 9.96 | ― | ― | -3.64% | -23.60% | |
48 Neutral | ¥54.76B | 88.80 | ― | 0.51% | 2.90% | ― | |
45 Neutral | ¥34.31B | -17.00 | ― | 3.11% | 1.46% | -436.55% |